NO20004966D0 - Use of anti-gp-39 antibody in the treatment and / or reversal of lupus and associated kidney disease - Google Patents
Use of anti-gp-39 antibody in the treatment and / or reversal of lupus and associated kidney diseaseInfo
- Publication number
- NO20004966D0 NO20004966D0 NO20004966A NO20004966A NO20004966D0 NO 20004966 D0 NO20004966 D0 NO 20004966D0 NO 20004966 A NO20004966 A NO 20004966A NO 20004966 A NO20004966 A NO 20004966A NO 20004966 D0 NO20004966 D0 NO 20004966D0
- Authority
- NO
- Norway
- Prior art keywords
- lupus
- reversal
- antibody
- treatment
- kidney disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5448898A | 1998-04-03 | 1998-04-03 | |
PCT/US1999/007321 WO1999051258A1 (en) | 1998-04-03 | 1999-04-02 | USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20004966D0 true NO20004966D0 (en) | 2000-10-02 |
NO20004966L NO20004966L (en) | 2000-12-04 |
Family
ID=21991433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20004966A NO20004966L (en) | 1998-04-03 | 2000-10-02 | Use of anti-gp-39 antibody in the treatment and / or reversal of lupus and associated kidney disease |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1067954A4 (en) |
JP (1) | JP2002510643A (en) |
KR (1) | KR20010072564A (en) |
CN (2) | CN100352497C (en) |
AU (1) | AU743824B2 (en) |
HU (1) | HUP0101689A3 (en) |
NO (1) | NO20004966L (en) |
TW (1) | TWI224969B (en) |
WO (1) | WO1999051258A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA41459A (en) | 2015-02-03 | 2017-12-12 | Als Therapy Development Inst | ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L ILLNESSES OR DISORDERS |
ES2944982T3 (en) | 2015-08-05 | 2023-06-27 | Janssen Biotech Inc | Anti-CD154 antibodies and methods of using them |
RU2770209C2 (en) | 2017-05-24 | 2022-04-14 | ЭйЭлЭс ТЕРАПИ ДЕВЕЛОПМЕНТ ИНСТИТЬЮТ | Cd40 ligand therapeutic antibodies |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5672347A (en) * | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
US5474771A (en) * | 1991-11-15 | 1995-12-12 | The Trustees Of Columbia University In The City Of New York | Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same |
CA2089229C (en) * | 1992-02-14 | 2010-04-13 | Alejandro A. Aruffo | Cd40cr receptor and ligands therefor |
US5876950A (en) * | 1995-01-26 | 1999-03-02 | Bristol-Myers Squibb Company | Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy |
US5833987A (en) * | 1995-06-07 | 1998-11-10 | Trustees Of Dartmouth College | Treatment of T cell mediated autoimmune disorders |
US6001358A (en) * | 1995-11-07 | 1999-12-14 | Idec Pharmaceuticals Corporation | Humanized antibodies to human gp39, compositions containing thereof |
TR199902191T2 (en) * | 1997-01-10 | 1999-12-21 | Biogen, Inc. | Lupus nephritis treatment with anti-CD40L compounds |
AU5623398A (en) * | 1997-03-07 | 1998-09-22 | Biogen, Inc. | Methods of therapeutic administration of anti-cd40l compounds |
WO1999000143A1 (en) * | 1997-06-27 | 1999-01-07 | Biogen, Inc. | Cd154 blockade therapy for autoimmune diseases |
-
1999
- 1999-04-02 CN CNB200410078988XA patent/CN100352497C/en not_active Expired - Fee Related
- 1999-04-02 JP JP2000542029A patent/JP2002510643A/en not_active Withdrawn
- 1999-04-02 WO PCT/US1999/007321 patent/WO1999051258A1/en not_active Application Discontinuation
- 1999-04-02 CN CNB998067563A patent/CN1173735C/en not_active Expired - Fee Related
- 1999-04-02 AU AU33796/99A patent/AU743824B2/en not_active Withdrawn - After Issue
- 1999-04-02 KR KR1020007011045A patent/KR20010072564A/en active Search and Examination
- 1999-04-02 EP EP99915237A patent/EP1067954A4/en not_active Withdrawn
- 1999-04-02 HU HU0101689A patent/HUP0101689A3/en unknown
- 1999-06-28 TW TW088105322A patent/TWI224969B/en not_active IP Right Cessation
-
2000
- 2000-10-02 NO NO20004966A patent/NO20004966L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1067954A4 (en) | 2004-08-18 |
KR20010072564A (en) | 2001-07-31 |
NO20004966L (en) | 2000-12-04 |
CN1757413A (en) | 2006-04-12 |
EP1067954A1 (en) | 2001-01-17 |
WO1999051258A1 (en) | 1999-10-14 |
AU3379699A (en) | 1999-10-25 |
CN1173735C (en) | 2004-11-03 |
TWI224969B (en) | 2004-12-11 |
CN1303301A (en) | 2001-07-11 |
AU743824B2 (en) | 2002-02-07 |
HUP0101689A3 (en) | 2004-08-30 |
JP2002510643A (en) | 2002-04-09 |
HUP0101689A2 (en) | 2001-08-28 |
CN100352497C (en) | 2007-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI970215A (en) | Use of droloxifene in the treatment of prostate disease, endometriosis and obesity | |
PT1083889E (en) | TETRA-HYDROFOLANTALINE COMPOUNDS AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
NO986052L (en) | Anticonvulsant sulphamate derivatives for use in the treatment of obesity | |
DE69836272D1 (en) | EXPERIMENTAL ASSEMBLY FOR THE DETERMINATION OF ANALYTES IN BODY FLUIDS | |
NO991700D0 (en) | Benzimidazole-2-carbamates for the treatment of viral infections and cancer | |
NO941440L (en) | Oil well cement slurries, preparation of the slurries, and use in well cementing | |
HK1043625A1 (en) | Kidney disease detection and treatment | |
EE05507B1 (en) | Use of rosuvastatin ZD4522) in the treatment of heterosgococcal family h percolesterolemia | |
DK1411064T3 (en) | Ganglioside-associated recombinant antibodies and their use in the diagnosis and treatment of tumors | |
NO983576D0 (en) | Well treatment fluids and methods | |
NO964075L (en) | Immunotherapeutic agent and its use | |
DK1017408T3 (en) | Use of tetrahydrolipstatin in the treatment of type II diabetes | |
NO20033443L (en) | Use of CD-2 binding agents in the treatment or prevention of skin disorders | |
NO872302L (en) | PESTICIDE MIXTURES AND PROCEDURES IN THE PREPARATION OF THESE. | |
NO986034D0 (en) | Combinations comprising VX 478, ZidovudÞn, FTC and / or 3TC for use | |
NO991160D0 (en) | Sulfate-containing polysaccharides and their applications in medical treatment | |
IS2207B (en) | Carbocyclic nucleus hemisulfate and its use in the treatment of viral infections | |
NO20020207L (en) | Biological materials and methods useful in the diagnosis and treatment of disease | |
PT1194038E (en) | COMPOSITION OF BREACH OF THE REST AND ITS USE | |
NO20004966D0 (en) | Use of anti-gp-39 antibody in the treatment and / or reversal of lupus and associated kidney disease | |
NO965247D0 (en) | Use of cross-linked hemoglobin in the treatment of subarakuoid hemorrhage | |
FI964809A0 (en) | In the case of use of the processing unit | |
NO20011901D0 (en) | Anti-convulsive derivatives useful in the treatment of alcohol dependence and abuse | |
NO890816D0 (en) | DEEMULATING MIXTURES AND PROCEDURES IN THE PREPARATION AND APPLICATION OF THEREOF. | |
DE69712239T2 (en) | Elimination and inhibition of the clinging of bivalve shells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |